CNTB Connect Biopharma Holdings Limited

NASDAQ
$2.55

Connect Biopharma Holdings Limited (CNTB) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.27 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +9.4% since its last earnings release on August 12, 2026.

Connect Biopharma Holdings Limited Beat Consensus Estimates
Wednesday, August 12, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · After Close
Earnings Whisper
-
vs ($0.27)
Rev est $2.6M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.54

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from our T cell-driven research.

Sector

Healthcare

Industry

Biotechnology